MAPT and Alzheimer disease: Even though no successful therapeutic strategies have been developed, several molecular mechanisms involved in the pathogenesis of AD have been suggested: Aβ overproduction and impaired Aβ clearance, dysregulated tau phosphorylation, altered glutamatergic neurotransmission, as well as astrocyte and microglia activation prior to the clinical onset [4,5,6].